Health and Fitness Health and Fitness
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Inergetics Shareholder Update
Tue, August 21, 2012
Mon, August 20, 2012
[ Mon, Aug 20th 2012 ] - Market Wire
Watson Launches Generic Xopenex
Sat, August 18, 2012
Fri, August 17, 2012
Thu, August 16, 2012
Wed, August 15, 2012
Tue, August 14, 2012
Mon, August 13, 2012
Fri, August 10, 2012
Thu, August 9, 2012
Wed, August 8, 2012
Tue, August 7, 2012
Mon, August 6, 2012
Fri, August 3, 2012
Thu, August 2, 2012
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012

Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference


//health-fitness.news-articles.net/content/2012/ .. w-lifesciences-management-access-conference.html
Published in Health and Fitness on Friday, August 10th 2012 at 4:01 GMT by Market Wire   Print publication without navigation


Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference -- DANBURY, Conn., Aug. 10, 2012 /PRNewswire/ --

Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference

[ ]

DANBURY, Conn., Aug. 10, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: [ BIOD ]) announced today that management will be presenting an overview of the company's technologies, development programs, and outlook at the 2012 Wedbush PacGrow Lifesciences Management Access Conference on Tuesday, August 14, 2012 at 1:55 p.m. EDT at the Le Parker Meridien hotel, New York City.

A live and archived webcast of the presentation will be accessible by visiting the Biodel website at [ www.biodel.com ] under "Webcasts" in the "News & Events" section.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.

BIOD-G

Contact: Seth D. Lewis, +1-646-378-2952

SOURCE Biodel Inc.



[ Back to top ]

RELATED LINKS
[ http://www.biodel.com ]


Publication Contributing Sources